news aktuell GmbH

CIVIS Media Prize 2022 – competition now open! / Closing date: 19 January 2022

29.11.2021 11:12:00 CET | news aktuell GmbH | Pressemelding

Del
The competition for the European CIVIS Media Prize is now open. European programmes on addressing migration, integration, cultural diversity and – linked to this – social cohesion can be submitted up to and including 19 January 2022. The CIVIS Media Prize honours outstanding TV, radio and online productions that promote peaceful coexistence between people from different geographic and cultural backgrounds.

Cologne, 29.11.2021

The CIVIS Awards are presented in four fields and in various categories:

  • VIDEO AWARD: Non-fiction programmes, fiction programmes and social media formats      (moving images)
  • AUDIO AWARD: Short programmes of up to six minutes, long programmes over six minutes      and podcasts
  • YOUNG C. AWARD (films, age restriction applies)
  • CINEMA AWARD (audience award)

The CIVIS TOP AWARD is an additional prize honouring the best production of the year in the AUDIO, VIDEO and YOUNG C. categories. No direct candidatures can be entered for the CIVIS TOP AWARD.

The total prize money is € 27,000.

Click here to register: https://registration.civismedia.eu/

The CIVIS Media Prize is sponsored by ARD, represented by WDR, together with the Freudenberg Foundation. ORF, SRG SSR, RTV Slovenia, ARTE, 3sat, phoenix, Deutsche Welle, Deutschlandradio and EBU are media partners. The Federal Government Commissioner for Integration, WDR mediagroup, the German Producers Alliance – Film & Television, VFF Verwertungsgesellschaft der Film- und Fernsehproduzenten and the European Union Agency for Fundamental Rights (FRA) are cooperation partners.

The non-profit CIVIS Media Foundation for Integration and Cultural Diversity in Cologne is responsible for organising the competition, jury meetings and award ceremony.

The European CIVIS Media Prize aims to encourage media professionals to deal with topics of migration, integration, cultural diversity and social cohesion in a creative, constructive and, where necessary, (self) critical way.

Follow CIVIS on Facebook | Instagram | Twitter | YouTube
#civis2022

Here are the conditions of participation 2022

Press contact
CIVIS Medienstiftung
für Integration und kulturelle Vielfalt in Europa
Ferdos Forudastan
Telefon: +49 (0)221 277 5870
E-Mail: info@civismedia.eu
www.civismedia.eu

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:54:06 CET | Press release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain.

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:39:09 CET | Press release

Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye